Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced a clinical program comprising of trials ...
New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.
Futurism on MSN3d
Cancer Vaccines Are Suddenly Looking Extremely PromisingWith the help of mRNA technology proven effective during the COVID era, researchers are now closer than ever to creating ...
Researchers are investigating whether a common cholesterol drug could be repurposed to treat HPV-positive cervical cancer.
Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
What is the Purpose of Cancer Clinical Trials? 2. What is the Role of Clinical Trials in Cancer Treatment, Including Risks ...
Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...
Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...
Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...
The CancerX Accelerator, hosted by Moffitt Cancer Center, has selected 14 startups for its second cohort, focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback